December 01, 2022

insitro

insitro Appoints Philip Tagari, Industry-Leading Scientist and Drug Hunter, as Chief Scientific Officer

November 15, 2022

Casma Therapeutics

Casma Therapeutics Raises $46.0 M in Series C Funding

November 10, 2022

Asher Bio

Asher Bio Presents New Preclinical Data at SITC 2022 Further Supporting Advancement of AB248 and AB821 as Highly Differentiated Cis-targeted Cancer Immunotherapies

November 10, 2022

Tango Therapeutics

Tango Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Highlights

November 09, 2022

Decibel Therapeutics

Decibel Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Update

Load More

Sign up for weekly portfolio news.